FR2834890B1 - Composition pharmaceutique orodispersible d'agomelatine - Google Patents

Composition pharmaceutique orodispersible d'agomelatine

Info

Publication number
FR2834890B1
FR2834890B1 FR0200792A FR0200792A FR2834890B1 FR 2834890 B1 FR2834890 B1 FR 2834890B1 FR 0200792 A FR0200792 A FR 0200792A FR 0200792 A FR0200792 A FR 0200792A FR 2834890 B1 FR2834890 B1 FR 2834890B1
Authority
FR
France
Prior art keywords
agomelatin
pharmaceutical composition
orodispersible pharmaceutical
orodispersible
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0200792A
Other languages
English (en)
French (fr)
Other versions
FR2834890A1 (fr
Inventor
Patrick Wuthrich
Herve Rolland
Marc Julien
Francois Tharrault
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0200792A priority Critical patent/FR2834890B1/fr
Application filed by Laboratoires Servier SAS filed Critical Laboratoires Servier SAS
Priority to AT03731733T priority patent/ATE324882T1/de
Priority to DK03731733T priority patent/DK1467724T3/da
Priority to CNB038027100A priority patent/CN1287780C/zh
Priority to MXPA04007198A priority patent/MXPA04007198A/es
Priority to US10/502,593 priority patent/US20050131071A1/en
Priority to BRPI0307072A priority patent/BRPI0307072B1/pt
Priority to PT03731733T priority patent/PT1467724E/pt
Priority to JP2003561589A priority patent/JP4335011B2/ja
Priority to ARP030100178A priority patent/AR038207A1/es
Priority to GE5625A priority patent/GEP20063818B/en
Priority to EA200400928A priority patent/EA007299B1/ru
Priority to SI200330266T priority patent/SI1467724T1/sl
Priority to EP03731733A priority patent/EP1467724B1/fr
Priority to PL370160A priority patent/PL204937B1/pl
Priority to AU2003220786A priority patent/AU2003220786B2/en
Priority to KR1020047011351A priority patent/KR100605798B1/ko
Priority to PCT/FR2003/000197 priority patent/WO2003061644A1/fr
Priority to CA2473201A priority patent/CA2473201C/fr
Priority to UA20040806965A priority patent/UA77752C2/ru
Priority to DE60304993T priority patent/DE60304993T2/de
Priority to NZ533843A priority patent/NZ533843A/en
Priority to ES03731733T priority patent/ES2262999T3/es
Publication of FR2834890A1 publication Critical patent/FR2834890A1/fr
Application granted granted Critical
Publication of FR2834890B1 publication Critical patent/FR2834890B1/fr
Priority to ZA2004/05153A priority patent/ZA200405153B/en
Priority to MA27775A priority patent/MA27101A1/fr
Priority to NO20043441A priority patent/NO333712B1/no
Priority to HK05108935A priority patent/HK1076742A1/xx
Priority to CY20061100898T priority patent/CY1105415T1/el
Priority to JP2009010024A priority patent/JP2009137994A/ja
Priority to US12/803,250 priority patent/US20100260840A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0200792A 2002-01-23 2002-01-23 Composition pharmaceutique orodispersible d'agomelatine Expired - Fee Related FR2834890B1 (fr)

Priority Applications (30)

Application Number Priority Date Filing Date Title
FR0200792A FR2834890B1 (fr) 2002-01-23 2002-01-23 Composition pharmaceutique orodispersible d'agomelatine
CA2473201A CA2473201C (fr) 2002-01-23 2003-01-22 Composition pharmaceutique orodispersible d'agomelatine
CNB038027100A CN1287780C (zh) 2002-01-23 2003-01-22 包含阿戈美拉汀的可在口中分散的药物组合物
MXPA04007198A MXPA04007198A (es) 2002-01-23 2003-01-22 Composicion farmaceutica oralmente dispersable que comprende agomelatina.
PCT/FR2003/000197 WO2003061644A1 (fr) 2002-01-23 2003-01-22 Composition pharmaceutique orodispersible d’agomelatine
BRPI0307072A BRPI0307072B1 (pt) 2002-01-23 2003-01-22 composição farmacêutica sólida orodispersível de agomelatina, comprimido e utilização de grânulos que consistem em lactose e amido co-secos
PT03731733T PT1467724E (pt) 2002-01-23 2003-01-22 Composicao farmaceutica orodispersavel de agomelatina
DK03731733T DK1467724T3 (da) 2002-01-23 2003-01-22 Farmaceutisk sammensætning med agomelatin til dispergering i mundhulen
ARP030100178A AR038207A1 (es) 2002-01-23 2003-01-22 Composicion farmaceutica dispersable oralmente de agomelatina
UA20040806965A UA77752C2 (ru) 2002-01-23 2003-01-22 Фармацевтическая композиция агомелатина, которая диспергируется в ротовой полости
EA200400928A EA007299B1 (ru) 2002-01-23 2003-01-22 Твердая диспергируемая во рту фармацевтическая композиция агомелатина
SI200330266T SI1467724T1 (sl) 2002-01-23 2003-01-22 Orodisperzibilen farmacevtski sestavek z agomelatinom
EP03731733A EP1467724B1 (fr) 2002-01-23 2003-01-22 Composition pharmaceutique orodispersible d'agomelatine
PL370160A PL204937B1 (pl) 2002-01-23 2003-01-22 Rozpadająca się w jamie ustnej (orodyspergowalna) kompozycja farmaceutyczna zawierająca agomelatynę
AU2003220786A AU2003220786B2 (en) 2002-01-23 2003-01-22 Orodispersible pharmaceutical composition comprising agomelatine
KR1020047011351A KR100605798B1 (ko) 2002-01-23 2003-01-22 아고멜라틴을 포함하는 구강내분산성 약제 조성물
AT03731733T ATE324882T1 (de) 2002-01-23 2003-01-22 In der mundhöhle dispergierbare pharmazeutische zusammensetzung mit agomelatin
JP2003561589A JP4335011B2 (ja) 2002-01-23 2003-01-22 アゴメラチンの口腔分散性医薬組成物
GE5625A GEP20063818B (en) 2002-01-23 2003-01-22 Orodispersible pharmaceutical composition comprising agomelatine
DE60304993T DE60304993T2 (de) 2002-01-23 2003-01-22 In der mundhöhle dispergierbare pharmazeutische zusammensetzung mit agomelatin
NZ533843A NZ533843A (en) 2002-01-23 2003-01-22 Orodispersible pharmaceutical composition comprising agomelatine
ES03731733T ES2262999T3 (es) 2002-01-23 2003-01-22 Composicion farmaceutica orodispersable de agomelatina.
US10/502,593 US20050131071A1 (en) 2002-01-23 2003-01-22 Orodispersible pharmaceutical composition of agomelatine
ZA2004/05153A ZA200405153B (en) 2002-01-23 2004-06-28 Orodispersible pharmaceutical composition comprising agomelatine
MA27775A MA27101A1 (fr) 2002-01-23 2004-07-12 Composition pharmaceutique orodispersible d'agomelatine
NO20043441A NO333712B1 (no) 2002-01-23 2004-08-18 Orodispersibel farmasoytisk sammensetning omfattende agomelatin
HK05108935A HK1076742A1 (en) 2002-01-23 2005-10-10 Orodispersible pharmaceutical composition comprising agomelatine
CY20061100898T CY1105415T1 (el) 2002-01-23 2006-06-30 Οροδιασπειρομενη φαρμακευτικη συνθεση αγομελατινης
JP2009010024A JP2009137994A (ja) 2002-01-23 2009-01-20 アゴメラチンの口腔分散性医薬組成物
US12/803,250 US20100260840A1 (en) 2002-01-23 2010-06-22 Orodispersible pharmaceutical composition of agomelatine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0200792A FR2834890B1 (fr) 2002-01-23 2002-01-23 Composition pharmaceutique orodispersible d'agomelatine

Publications (2)

Publication Number Publication Date
FR2834890A1 FR2834890A1 (fr) 2003-07-25
FR2834890B1 true FR2834890B1 (fr) 2004-02-27

Family

ID=27589556

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0200792A Expired - Fee Related FR2834890B1 (fr) 2002-01-23 2002-01-23 Composition pharmaceutique orodispersible d'agomelatine

Country Status (28)

Country Link
US (2) US20050131071A1 (ru)
EP (1) EP1467724B1 (ru)
JP (2) JP4335011B2 (ru)
KR (1) KR100605798B1 (ru)
CN (1) CN1287780C (ru)
AR (1) AR038207A1 (ru)
AT (1) ATE324882T1 (ru)
AU (1) AU2003220786B2 (ru)
BR (1) BRPI0307072B1 (ru)
CA (1) CA2473201C (ru)
CY (1) CY1105415T1 (ru)
DE (1) DE60304993T2 (ru)
DK (1) DK1467724T3 (ru)
EA (1) EA007299B1 (ru)
ES (1) ES2262999T3 (ru)
FR (1) FR2834890B1 (ru)
GE (1) GEP20063818B (ru)
HK (1) HK1076742A1 (ru)
MA (1) MA27101A1 (ru)
MX (1) MXPA04007198A (ru)
NO (1) NO333712B1 (ru)
NZ (1) NZ533843A (ru)
PL (1) PL204937B1 (ru)
PT (1) PT1467724E (ru)
SI (1) SI1467724T1 (ru)
UA (1) UA77752C2 (ru)
WO (1) WO2003061644A1 (ru)
ZA (1) ZA200405153B (ru)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2834889B1 (fr) * 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible
US20030228370A1 (en) * 2002-06-11 2003-12-11 Michel Serpelloni Orodispersible solid pharmaceutical form
AR047553A1 (es) * 2003-07-04 2006-01-25 Lundbeck & Co As H La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina
FR2884714B1 (fr) * 2005-04-20 2011-05-06 Servier Lab Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles bipolaires
FR2890564B1 (fr) * 2005-09-09 2007-10-19 Servier Lab Nouvelle association entre l'agomelatine et un inhibiteur de la recapture de la noradrenaline et les compositions pharmaceutiques qui la contiennent
FR2890562B1 (fr) * 2005-09-09 2012-10-12 Servier Lab Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles du sommeil chez le patient deprime
FR2894475B1 (fr) * 2005-12-14 2008-05-16 Servier Lab Composition pharmaceutique orodispersible pour administra- -tion oromucosale ou sublinguale d'agomelatine
EP1849459A1 (en) * 2006-03-06 2007-10-31 Teva Pharmaceutical Industries Ltd. Ezetimibe compositions
CN101206200B (zh) * 2006-12-19 2011-12-28 北京德众万全药物技术开发有限公司 一种分离分析阿戈美拉汀中间体及其终产品的hplc方法
US7608737B2 (en) * 2007-05-01 2009-10-27 Concert Pharmaceuticasl Inc. Naphthyl(ethyl)acetamides
EP2359813A1 (en) * 2010-02-04 2011-08-24 Ratiopharm GmbH Pharmaceutical composition comprising N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamid
CN101836966A (zh) * 2010-05-27 2010-09-22 北京万全阳光医药科技有限公司 一种含有阿戈美拉汀的口腔崩解片
CN102579415B (zh) * 2011-01-14 2014-11-05 成都康弘药业集团股份有限公司 一种含有阿戈美拉汀的口腔粘膜或舌下给药的药物组合物
AR084865A1 (es) 2011-01-17 2013-07-10 Takeda Pharmaceutical Preparacion de desintegracion rapida, comprimido dispersable por via oral
US8426461B2 (en) 2011-01-17 2013-04-23 Takeda Pharmaceutical Company Limited Orally dispersible tablet
WO2012130837A1 (en) * 2011-03-28 2012-10-04 Ratiopharm Gmbh Solid agomelatine in non-crystalline form
FR2978916B1 (fr) * 2011-08-10 2013-07-26 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
EP2562151A1 (en) * 2011-08-25 2013-02-27 Dr. Reddy's Laboratories Ltd. Processes for the preparation of agomelatine and its intermediates
EP2765985A1 (en) 2011-10-14 2014-08-20 Takeda Pharmaceutical Company Limited Orally dispersible tablet
CN103169669B (zh) * 2011-12-26 2015-06-17 中国人民解放军军事医学科学院毒物药物研究所 阿戈美拉汀包衣微丸以及可在口中分散的药物组合物
EP2872129B1 (en) 2012-07-16 2017-03-08 ratiopharm GmbH Complex of agomelatine and cyclodextrin
CN102988315B (zh) * 2012-09-28 2017-11-17 浙江华海药业股份有限公司 阿戈美拉汀固体制剂的制备方法
FR3001894A1 (fr) * 2013-02-08 2014-08-15 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
EP2810647A1 (en) 2013-06-06 2014-12-10 Zentiva, a.s. Pharmaceutical formulations comprising agomelatine in the form of agomelatine co-crystal with an organic acid
ES2645223T3 (es) 2013-06-06 2017-12-04 Zentiva, K.S. Formulaciones de agomelatina que comprenden agomelatina en forma de co-cristales
CN103816129B (zh) * 2014-02-27 2020-04-28 浙江华海药业股份有限公司 阿戈美拉汀口崩片
CN104586797A (zh) * 2015-01-05 2015-05-06 万特制药(海南)有限公司 阿戈美拉汀分散片及其制备方法
CN106333929A (zh) * 2016-09-24 2017-01-18 万特制药(海南)有限公司 一种含有阿戈美拉汀的分散片及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3505433A1 (de) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
DE3506276C1 (de) * 1985-02-22 1986-04-24 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring Direkttablettiermittel
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2710265B1 (fr) * 1993-09-22 1995-10-20 Adir Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs.
NZ278678A (en) * 1994-01-31 1998-03-25 Yamanouchi Pharma Co Ltd Compressed moulded tablet with quick disintegration/dissolution in the mouth, mixture of low and high moldable saccharides as carriers
HU224035B1 (hu) * 1996-05-13 2005-05-30 Novartis Consumer Health S.A. Bukkális adagolórendszer
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
NZ507271A (en) * 1998-03-06 2003-03-28 Eurand Internat S Fast disintegrating tablets
JP2000273039A (ja) * 1999-01-20 2000-10-03 Taisho Pharmaceut Co Ltd 口腔内崩壊性組成物
ES2292414T3 (es) * 2000-07-27 2008-03-16 Roquette Freres Granulos a base de almidon y de lactosa.
UA80393C2 (ru) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтическая композиция, которая содержит ингибитор фдэ 4, диспергированный в матрице
FR2834889B1 (fr) * 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible

Also Published As

Publication number Publication date
MA27101A1 (fr) 2004-12-20
US20050131071A1 (en) 2005-06-16
ATE324882T1 (de) 2006-06-15
JP4335011B2 (ja) 2009-09-30
BRPI0307072B1 (pt) 2017-05-02
WO2003061644A1 (fr) 2003-07-31
DK1467724T3 (da) 2006-08-28
JP2005523253A (ja) 2005-08-04
EP1467724A1 (fr) 2004-10-20
CN1287780C (zh) 2006-12-06
CY1105415T1 (el) 2010-04-28
UA77752C2 (ru) 2007-01-15
EA007299B1 (ru) 2006-08-25
FR2834890A1 (fr) 2003-07-25
HK1076742A1 (en) 2006-01-27
NO333712B1 (no) 2013-09-02
CA2473201C (fr) 2010-08-17
PL204937B1 (pl) 2010-02-26
ES2262999T3 (es) 2006-12-01
GEP20063818B (en) 2006-05-10
ZA200405153B (en) 2005-08-31
NZ533843A (en) 2005-08-26
EA200400928A1 (ru) 2004-12-30
AR038207A1 (es) 2005-01-05
CN1622804A (zh) 2005-06-01
KR20040075102A (ko) 2004-08-26
BR0307072A (pt) 2004-12-28
PT1467724E (pt) 2006-08-31
PL370160A1 (en) 2005-05-16
AU2003220786B2 (en) 2007-08-02
US20100260840A1 (en) 2010-10-14
NO20043441L (no) 2004-08-18
JP2009137994A (ja) 2009-06-25
KR100605798B1 (ko) 2006-08-01
SI1467724T1 (sl) 2006-08-31
DE60304993T2 (de) 2007-01-18
CA2473201A1 (fr) 2003-07-31
MXPA04007198A (es) 2004-10-29
DE60304993D1 (de) 2006-06-08
EP1467724B1 (fr) 2006-05-03

Similar Documents

Publication Publication Date Title
FR2834890B1 (fr) Composition pharmaceutique orodispersible d'agomelatine
DE50206657D1 (de) Pharmazeutische zusammensetzung zur behandlung von multiple sklerose
IS7714A (is) Lyfjasamsetningar úr módafíníl
MA27116A1 (fr) Preparation pharmaceutique contenant de l'oxycodon e et du naloxone
PT1066027E (pt) Composicao farmaceutica de topiramato
FR2894475B1 (fr) Composition pharmaceutique orodispersible pour administra- -tion oromucosale ou sublinguale d'agomelatine
DE60232251D1 (de) Pharmazeutische zusammensetzungen zur behandlung von asthma
EE200200393A (et) Glüburiidi ravimkoostis
ITMI20001732A0 (it) Composizioni farmaceutiche per il trattamento di mucositi e stomatiti
AU2003220786A1 (en) Orodispersible pharmaceutical composition comprising agomelatine
MA26882A1 (fr) COMPOSITIONS PHARMACEUTIQUES D'INHIBITEURS ET GLYCOGèNE-PHOSPHORYLASE
IS2707B (is) Nýjar lyfjasamsetningar úr módafíníli
ITMI981774A0 (it) Composizioni farmaceutiche ad attivita' analgesica
FR2834896B1 (fr) Composition pharmaceutique orodispersible d'ivabradine
FR2857263B1 (fr) Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
FR2834893B1 (fr) Composition pharmaceutique orodispersible de perindopril
FR2812811B1 (fr) Composition pharmaceutique contenant du citalopram
ITMI20021684A1 (it) Composizione farmaceutica di peptide nasale
DE60329614D1 (de) Polymerzusammensetzung sowie diese enthaltende darreichungsformen
EE200300468A (et) Pravastatiini stabiilne farmatseutiline kompositsioon
FR2857593B1 (fr) Composition pharmaceutique orodispersible d'un compose antithrombotique
FR2847818B1 (fr) Composition pharmaceutique a base d'acide hyaluronique
FR2848454B1 (fr) Composition pharmaceutique comprenant une association de calcitriol et d'un corticosteroide
FR2839888B1 (fr) Complexes d'inclusion de fenofibrate et de cyclodextrine et composition pharmaceutique les renfermant
FR2834892B1 (fr) Composition pharmaceutique orodispersible de mitiglinide

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20081029